EPID-based 3D dosimetry for pre-treatment FFF VMAT stereotactic body radiotherapy plan verification using dosimetry Check.

Phys Med

Medical Physics Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy; School of Engineering, Cardiff University, Cardiff, UK.

Published: January 2021

Purpose: The software Dosimetry Check (DC) reconstructs the 3D dose distribution on CT images data set by using EPID measured signal. This study aimed to evaluate DC for stereotactic body radiotherapy (SBRT) with unflattened photon beams (FFF) for dosimetric independent plan verification in pre-treatment modality.

Methods: DC v.4.1 was configured for Varian TrueBeam STx FFF beams equipped with EPID aS-1200. The DC FFF models were tested using arc open fields (from 1×1 cm to 15×15 cm) and VMAT (Volumetric Modulated Arc Therapy) SBRT plans on phantom and patient CTs. DC dose distributions (D) were compared with that calculated by Eclipse with Acuros XB algorithm (D) and one measured by Octavius 1000 SRS detector (D). All differences were quantified in terms of the local 3D gamma passing rate (%GP), DVH and point dose differences.

Results: DC was configured for FFF VMAT using an appropriate correction procedure. %GP (mean±standard deviation) of D-D was 96.3±2.7% for open fields whereas it was 90.1±5.9% for plans on homogeneous phantom CT. However, average %GP of D-D was 95.0±4.1 for treatments on patient CT. The fraction of plans passing the %GP DQA tolerance level [10% (50%) of maximum dose threshold] were 20/20 (14/20) and 18/20 (16/20) for OCT on phantom CT and DC on patient CT, respectively.

Conclusions: DC characterization for FFF beams was performed. For stereotactic VMAT plan verifications DC showed good agreement with TPS whereas underlined discrepancies with Octavius in the high dose regions. A customized tolerance level is required for EPID-based VMAT FFF pre-treatment verification when DC system is applied.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmp.2020.12.014DOI Listing

Publication Analysis

Top Keywords

fff vmat
8
stereotactic body
8
body radiotherapy
8
plan verification
8
dosimetry check
8
fff beams
8
open fields
8
phantom patient
8
tolerance level
8
fff
7

Similar Publications

This study aimed to evaluate the dosimetric and clinical outcomes of flattening filter (FF) versus flattening filter-free (FFF) beams in head and neck cancer (HNC) patients treated with volumetric modulated arc therapy (VMAT). Twenty-four patients with 70/59.4/54 Gy dose prescribed in 33 fractions with simultaneous integrated boost treatment were retrospectively analyzed to compare treatment delivery efficiency, target coverage, sparing of organs at risk (OARs), and remaining volume at risk (RVR) in two HNC groups (nasopharyngeal and oropharyngeal).

View Article and Find Full Text PDF

Background: Stereotactic arrythmia radioablation (STAR) is a noninvasive technique to treat ventricular tachycardia (VT). Management of cardiorespiratory motion plays an essential role in VT-STAR treatments to improve treatment outcomes by reducing positional uncertainties and increasing dose conformality. Use of an electrocardiogram (ECG) signal, acquired in real-time, as a surrogate to gate the beam has the potential to fulfil that intent.

View Article and Find Full Text PDF

Purpose: To compare the effect of two linacs designs on fetal dose sparing on a pregnant patient, including estimation of the fetal dose, and the effect of a lead apron.

Methods: A patient with a high-grade sarcoma located in the right knee/lower thigh was prescribed 51 Gy (1.7 Gy/Fx) with a simultaneous-integrated-boost (SIB) of 60 Gy to a smaller volume, starting in the 26th gestational week.

View Article and Find Full Text PDF

Purpose: To investigate the effect of ion recombination ( ) and polarity ( ) correction factors on percentage depth dose (PDD) curves for three ion chambers, using flat and flattening filter free (FFF) beams, across different broad field sizes. A method to assess these effects and their corresponding corrections is proposed.

Methods: and were evaluated following the IAEA TRS-398 protocol for three ion chambers: PTW Semiflex-3D-31021, PinPoint-3D-31022, and Semiflex-31010.

View Article and Find Full Text PDF

Introduction: This study primarily aims to investigate the suitability of Halcyon in the context of cervical-thoracic esophageal cancer by exploring the dosimetric quality and delivery efficiency of Halcyon plans with different arc configurations. Additionally, it compares these findings with the dosimetric indices and delivery efficiency of TrueBeam and TomoTherapy accelerators, focusing on their capability to optimize protection for organs at risk (OARs) while maintaining efficient treatment delivery strategies.

Methods: This retrospective study involved 26 patients diagnosed with cervical-thoracic esophageal cancer, and new radiotherapy plans were created using Halcyon, TrueBeam, and TomoTherapy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!